tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Immunovant price target lowered to $35 from $51 at H.C. Wainwright
PremiumThe FlyImmunovant price target lowered to $35 from $51 at H.C. Wainwright
2M ago
Immunovant’s Strategic Developments and Financial Strength Justify Buy Rating
Premium
Ratings
Immunovant’s Strategic Developments and Financial Strength Justify Buy Rating
2M ago
Immunovant, Inc. Reports Strategic Progress and Financial Results
Premium
Company Announcements
Immunovant, Inc. Reports Strategic Progress and Financial Results
2M ago
Immunovant’s Strategic Leadership and Portfolio Expansion Justify Buy Rating
PremiumRatingsImmunovant’s Strategic Leadership and Portfolio Expansion Justify Buy Rating
3M ago
Immunovant downgraded to Neutral from Buy at UBS
Premium
The Fly
Immunovant downgraded to Neutral from Buy at UBS
3M ago
Immunovant’s Strategic Developments and Growth Potential Drive Buy Rating
Premium
Ratings
Immunovant’s Strategic Developments and Growth Potential Drive Buy Rating
3M ago
Immunovant’s Competitive Edge and Growth Potential: Buy Rating Supported by IMVT-1402 Approval and Promising Study Results
PremiumRatingsImmunovant’s Competitive Edge and Growth Potential: Buy Rating Supported by IMVT-1402 Approval and Promising Study Results
3M ago
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
4M ago
Buy Rating Affirmed for IMVT-1402: Promising Study Results and Strategic Focus in FcRn Space
Premium
Ratings
Buy Rating Affirmed for IMVT-1402: Promising Study Results and Strategic Focus in FcRn Space
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100